PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Apr-2022 Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics Epitopea
26-Apr-2022 PolyPeptide Group announces results of the annual General Meeting 2022 PolyPeptide Group
26-Apr-2022 SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102 in Patients with Gastric and Pancreatic Cancer B3C newswire
26-Apr-2022 Novartis UK announces charity partnerships to support social mobility commitments Novartis UK
26-Apr-2022 APEIRON shareholders approve new group structure geared towards enabling innovation and growth APEIRON Biologics AG
26-Apr-2022 ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies B3C newswire
26-Apr-2022 Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing Relief Therapeutics Holding SA
25-Apr-2022 Medacta Announces First Lumbar Fusion Procedure with NextAR Spine Augmented Reality Surgical Application in US Medacta Group SA
25-Apr-2022 Accelerate Diagnostics Presents New Data at ECCMID 2022 Demonstrating Rapid and Accurate Results Using Automated Accelerate Arc™ Module and BC Kit B3C newswire
25-Apr-2022 Biotest AG: Grifols acquires majority of voting rights in Biotest Biotest AG
25-Apr-2022 Exogene raises $2 million for its AI platform to discover cell therapies for cancer Sciad Newswire
25-Apr-2022 PharmaSGP expects to see clear double-digit revenue and profit growth in 2022 PharmaSGP Holding SE
25-Apr-2022 License partner of Xlife Sciences announces successful completion of phase 1 of in-vivo trial for ATROSIMAB – out-licensing of the compound intended Xlife Sciences AG
22-Apr-2022 CureVac to Report Fourth Quarter and Full-Year 2021 Financial Results and Business Updates on April 28, 2022 CureVac
22-Apr-2022 Weekly Life Science News Round Up: 18th – 22nd April PharmiWeb.Jobs
22-Apr-2022 Hikma completes acquisition of Custopharm Hikma Pharmaceuticals PLC
22-Apr-2022 Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil Relief Therapeutics Holding SA
22-Apr-2022 Medacta Group SA publishes 2022 Annual General Meeting invitation Medacta Group SA
21-Apr-2022 Annual General Meeting - Shareholders approve all proposals of the Board of Directors COLTENE Holding AG
21-Apr-2022 CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study CureVac